Everything You Need to Know About

Echinacea (Echinacea angustifolia/purpurea)

Botanical family: Asteraceae
Parts used: Roots Stems Leaves Flowers
Echinacea (Echinacea angustifolia/purpurea)

Overview and Health Benefits

Widely recognised for its immune-boosting properties, echinacea has a long history of medicinal use, particularly in mitigating the severity and duration of respiratory infections, such as the common cold and flu. Also known as purple coneflower, this herb's roots in herbal medicine extend back to Native American traditions, where it was used for its broad spectrum of medicinal properties, including its ability to fight infections, reduce inflammation, and promote wound healing. Modern research supports these uses, particularly highlighting Echinacea's role in modulating immune responses and providing natural protection against various pathogens (McIntyre, 2019; Mills & Bone, 2013; WHO, 1999).

 

Key Benefits:

  • Immune System Support: Echinacea is particularly valued for its ability to enhance immune function. Studies show that Echinacea increases the activity of white blood cells, including natural killer cells and monocytes, which are essential for combating infections (Goel et al., 2005). Polysaccharides in Echinacea, such as heteroxylan and arabinogalactan, are key contributors to this immune-enhancing effect by promoting the production of immune cells and cytokines like interleukin-1 and tumour necrosis factor (Wagner, 1988; WHO, 1999; Mills & Bone, 2013). Moreover, Echinacea intake has been linked to increased expression of leukocyte heat shock proteins (hsp70), which play a crucial role in immune regulation (Roesler et al., 1991, as cited in WHO, 1999).
  • Anti-Inflammatory Properties: The anti-inflammatory effects of Echinacea make it beneficial for treating inflammatory conditions such as sore throats, ear infections and inflammatory skin conditions. It works by inhibiting the enzyme hyaluronidase, which breaks down hyaluronic acid, a vital component of connective tissue, thereby reducing inflammation and promoting tissue healing (Büsing, 1952, as cited in WHO, 1999; McIntyre, 2019). Additionally, alkylamides found in Echinacea have been shown to inhibit the activity of 5-lipoxygenase, further contributing to its anti-inflammatory properties (Wagner et al., 1988). In clinical settings, Echinacea has also been demonstrated to effectively reduce the inflammatory response in patients with upper respiratory infections (Barrett et al., 2010).
  • Antiviral Activity: Echinacea has demonstrated significant antiviral properties, particularly in inhibiting the replication of various strains of influenza virus and other respiratory pathogens. Its effectiveness is most pronounced when used at the onset of infection, helping to prevent viruses from penetrating cells and establishing infection (Buhner, 2012; Mills & Bone, 2013; WHO, 1999). In vitro studies have also shown that chicoric acid, a compound found in Echinacea purpurea, can inhibit viral replication by more than 50% (Müller-Jakic et al., 1994). Additionally, a randomised controlled trial found that Echinacea was effective in reducing the incidence and severity of colds and respiratory infections (Schöneberger, 1992, as cited in WHO, 1999).
  • Topical Antiseptic: Echinacea's antiseptic properties make it highly effective when applied topically to treat burns, wounds, and other skin conditions. The herb's ability to prevent infection and promote healing has been well documented, making it a valuable natural remedy for skin ailments (Viehmann, 1978, as cited in WHO, 1999; McIntyre, 2019). For example, an ointment containing Echinacea purpurea was found to significantly improve healing in 85.5% of cases involving inflammatory skin conditions, burns, and wounds (Viehmann, 1978, as cited in WHO, 1999). Furthermore, Echinacea-based treatments have shown efficacy in managing herpes simplex virus outbreaks and in promoting wound healing by stimulating fibroblast activity (WHO, 1999).
  • Respiratory Health: As previously mentioned, echinacea is commonly used to relieve symptoms of upper respiratory tract infections. It has been shown to reduce the duration and severity of symptoms by stimulating immune activity and inhibiting the growth of pathogens that cause these infections (Barrett et al., 2010; WHO, 1999; Mills & Bone, 2013). Clinical trials have demonstrated that Echinacea purpurea is effective in preventing and treating colds, particularly in individuals exposed to stress, such as athletes (Schöneberger, 1992; Barrett et al., 2010). Additionally, the herb's ability to enhance phagocytosis and stimulate the production of interferon further supports its role in respiratory health (WHO, 1999).

Safety

Individuals with allergies to plants in the Asteraceae family, such as daisies, may be at risk of allergic reactions when using Echinacea (WHO, 1999). Additionally, while Echinacea is widely used to enhance immune function, there are theoretical concerns regarding its use in individuals with systemic diseases, such as tuberculosis, HIV, and autoimmune conditions, as it may potentially exacerbate these conditions by overstimulating the immune system. However, current scientific data on this matter is inconclusive (WHO, 1999). Furthermore, the internal use of Echinacea should not exceed eight successive weeks, as prolonged use may lead to adverse effects, including liver enzyme elevations (WHO, 1999). Pregnant and nursing women  should exercise caution, as there is insufficient evidence to ensure the safety of Echinacea during pregnancy and lactation (WHO, 1999). It should be avoided in children under 12 years old (Taylor et al., 2003). As with any herbal remedy, it is advisable to consult with a qualified medical herbalist before using Echinacea, especially if you have a pre-existing medical condition or are taking any prescription medications.


Key Body Systems Echinacea (Echinacea angustifolia/purpurea) relates to

Echinacea (Echinacea angustifolia/purpurea)
Immune System
Echinacea (Echinacea angustifolia/purpurea)
Lymphatic System
Echinacea (Echinacea angustifolia/purpurea)
Respiratory system
Echinacea (Echinacea angustifolia/purpurea)
Skin

Energetics

Echinacea (Echinacea angustifolia/purpurea)
Cooling
Echinacea (Echinacea angustifolia/purpurea)
Drying

Key actions

  • Immunostimulant
  • Immunomodulatory
  • Depurative
  • Anti-inflammatory
  • Lymphatic
Echinacea (Echinacea angustifolia/purpurea)

Key uses

  • Infection (bacterial, viral, fungal)
  • Upper respiratory infections
  • Enhancing immune response
  • Sinusitis
  • Acne, abscesses, boils and poorly healing wounds

Where to Find Echinacea (Echinacea angustifolia/purpurea)

Echinacea (Echinacea angustifolia/purpurea)

Echinacea, often known as the purple coneflower, is a striking and resilient herbaceous perennial that belongs to the Asteraceae family, a large family that also includes daisies, sunflowers, and asters. This family is characterised by its composite flowers, which are actually clusters of many tiny florets, creating the appearance of a single bloom. 

Echinacea is easily recognised by its distinctive flower heads, which feature a prominent, spiny, cone-shaped centre surrounded by drooping, vibrant petals that range in colour from soft pink to deep purple. The plant typically grows between 60 to 180 centimetres in height, with a stout, erect stem that is often covered in bristly hairs. Its leaves are rough to the touch, lanceolate, and arranged alternately along the stem, with coarsely serrated or smooth edges depending on the species.

Echinacea thrives in well-drained soils, often favouring dry, open prairies, meadows, and forest edges. It prefers full sun but can tolerate partial shade, and it is remarkably drought-resistant once established. This hardy plant is native to central and eastern North America, particularly the Great Plains, but has been successfully cultivated in gardens and farms across Europe and other temperate regions. Echinacea’s deep tap roots allow it to survive in less fertile soils and contribute to its role as a pioneer species in restoring native landscapes. The plant’s vibrant flower heads and unique central cone make it a standout in landscapes where it is present, easy to spot even from a distance.

References

Barrett, B., Brown, R., Rakel, D., Mundt, M., Bone, K., Barlow, S., & Ewers, T. (2010). Echinacea for treating the common cold: A randomized trial. Annals of Internal Medicine, 153(12), 769-777. https://doi.org/10.7326/0003-4819-153-12-201012210-00003 

Büsing, K. H. (1952). Hyaluronidase inhibition by Echinacin. Arzneimittel-Forschung, 2(6), 467-469.

Buhner, S. (2012). Herbal antibiotics: Natural alternatives for treating drug-resistant bacteria. Storey Publishing.

Goel, V., Lovlin, R., Chang, C., Slama, J. V., Barton, R., Gahler, R., Bauer, R., Goonewardene, L., & Basu, T. K. (2005). A proprietary extract from the echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold. Phytotherapy Research, 19(8), 689-694. https://doi.org/10.1002/ptr.1733 

McIntyre, A. (2019). The complete herbal tutor. Aeon Books.

Mills, S., & Bone, K. (2013). Principles and practice of phytotherapy (2nd ed.). Elsevier.

Müller-Jakic, B., Breu, W., Pröbstle, A., Redl, K., Greger, H., & Bauer, R. (1994). In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Medica, 60(1), 37-40. https://doi.org/10.1055/s-2006-959404 

Roesler, J., Emmendörffer, A., Steinmüller, C., Luettig, B., Wagner, H., & Lohmann-Matthes, M. L. (1991). Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. International Journal of Immunopharmacology, 13(7), 931-941. https://doi.org/10.1016/0192-0561(91)90046-a 

Schöneberger, D. (1992). The influence of immune-stimulating effects of pressed juice from Echinacea purpurea on the course and severity of colds. Forum Immunologie, 8, 2–12.

Taylor, J. A., Weber, W., Standish, L., Quinn, H., Goesling, J., McGann, M., & Calabrese, C. (2003). Efficacy and safety of echinacea in treating upper respiratory tract infections in children: A randomized controlled trial. JAMA, 290(21), 2824-2830. https://doi.org/10.1001/jama.290.21.2824 

Viehmann, P. (1978). Results of treatment with an echinacea-based ointment. Erfahrungsheilkunde, 27(5), 353-358.

Wagner, H., Stuppner, H., Schäfer, W., & Zenk, M. (1988). Immunologically active polysaccharides of Echinacea purpurea cell cultures. Phytochemistry, 27(1), 119-126. https://doi.org/10.1016/0031-9422(88)80601-0 

World Health Organization. (1999). WHO monographs on selected medicinal plants: Volume 1. World Health Organization. https://iris.who.int/bitstream/handle/10665/42052/9241545178.pdf